Back

Utilization patterns of potent GLP-1-RA among patients with type 2 diabetes in clinical practice

31 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Therapeutic advancements in type 2 diabetes mellitus Antidiabetic Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Sofiya Matseyko

(Germany)

3 More presentations in this session

Presentation thumbnail
Characterization of cardiovascular risk profile and therapeutic management in patients with type 2 diabetes mellitus: insight from the CardioMET Italian registry
Doctor F. Marzano (Naples, IT)
Abstract
Presentation thumbnail
Cardiovascular effects of tirzepatide in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials
Professor M. Saffi (Porto Alegre, BR)
Abstract
Presentation thumbnail
Effect of glucagon-like peptide-1 receptor agonists on nonfatal cardiovascular events in patients with type 2 diabetes and high cardiovascular risk
Doctor K. Abraham (Staten Island, US)
Abstract

Access the full session

Session thumbnail
Therapeutic advancements in type 2 diabetes mellitus

The Event

Event poster

ESC Congress 2026

31 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
GLP-1 receptor agonists as an opportunity for patients with atherosclerotic cardiovascular disease as well as obesity in Germany
1 September 2025
thumbnail
Congress Presentation
SGLT2i uptake among heart failure patients with reduced ejection fraction: ongoing prescriber hesitancy and how to address this.
29 August 2022
thumbnail
Congress Presentation
Persistence and Adherence to GLP-1 RA treatment in Type 2 Diabetes Mellitus: a Nationwide registry study
31 August 2024
thumbnail
Congress Presentation
Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes patients: a propensity score-matched study
27 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources